IL18 and cholangiocarcinoma: Since IL-2/IL-18-induced NK cells both kill CCA cells and express markers associated with antigen-presenting cells, it is plausible that they could serve as antigen-presenting cells, presenting CCA-derived antigens to both CD4+ αβ T cells and CD8+ αβ T cells.